Title | Creator | Date | ||
---|---|---|---|---|
1 | Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor Use | Albert S. Li, MD; Howard D. Pomeranz, MD, PhD | 2016-12 | |
2 | Cases of Ischemic Optic Neuropathy Associated With Phosphodiesterase-5 Inhibitor Use Reported to the Food and Drug Administration Adverse Event Reporting System | Howard D. Pomeranz, MD, PhD | 2016-06 | |
3 | Relationship Between Age, Gender, and Race in Patients Presenting With Myasthenia Gravis With Only Ocular Manifestations | Jason H. Peragallo, MD; Elena Bitrian, MD; Mark J. Kupersmith, MD; Fritz Zimprich, MD, PhD; Thomas J. Whittaker, MD, JD; Michael S. Lee, MD; Beau B. Bruce, MD, PhD | 2016-03 |